Document is current
Any future updates will be listed below
-
Authors
Yamamoto, Tatsuro
Hirosue, Akiyuki
Nakamoto, Masafumi
Yoshida, Ryoji
Sakata, Junki
Matsuoka, Yuichiro
Kawahara, Kenta
Nagao, Yuka
Nagata, Masashi
Takahashi, Nozomu
Hiraki, Akimitsu
Shinohara, Masanori
Nakao, Mitsuyoshi
Saitoh, Noriko
Nakayama, Hideki
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (19K23736, 18K09727, 25116009, 16H04744, 18H05531)
Naito Foundation
Takeda Science Foundation
Princess Takamatsu Cancer Research Fund
- License Information
-
More Information
Article History
Received: 22 November 2019
Accepted: 29 April 2020
First Online: 5 June 2020
Ethics approval and consent to participate
: This study was performed with the approval of the Ethics Committee of Kumamoto University, and written informed consent was obtained from all patients (project identification code: RINRI No. 1427). This study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: Our original ChIP-seq data sets have been deposited in the DNA Data Bank of Japan (DDBJ) Sequence Read Archive with the accession number DRA005541. Our Microarray data sets have been deposited in the NCBI with the accession number GSE140858. The ChIP-seq data sets used in this work are publicly available.<sup>37</sup> Other data that support the findings of this study are available from the corresponding author upon reasonable request.
: The authors declare no competing interests.
: This work was supported by JSPS KAKENHI (19K23736 [to T.Y.], 18K09727 [to A.H.], 25116009, 16H04744, 18H05531, 18K19310 [to N.S.]) and by research grants from The Naito Foundation, Takeda Science Foundation and Princess Takamatsu Cancer Research Fund to N.S.
